Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Jennifer Trujillo to Humans

This is a "connection" page, showing publications Jennifer Trujillo has written about Humans.

 
Connection Strength
  
 
 
0.457
  
  1. Ryan M, Megyeri S, Nuffer W, Trujillo JM. The potential role of GLP-1 receptor agonists in osteoarthritis. Pharmacotherapy. 2025 Mar; 45(3):177-186.
    View in: PubMed
    Score: 0.025
  2. Trujillo JM, Wettergreen SA, Bain DL. A doctor of pharmacy curriculum revision process focused on curricular overload. Am J Pharm Educ. 2024 Aug; 88(8):100758.
    View in: PubMed
    Score: 0.024
  3. Trujillo JM, Cain J. Simplifying the PharmD Curriculum. Am J Pharm Educ. 2023 07; 87(7):100029.
    View in: PubMed
    Score: 0.021
  4. Tall Bull S, Nuffer W, Trujillo JM. Tirzepatide: A novel, first-in-class, dual GIP/GLP-1 receptor agonist. J Diabetes Complications. 2022 12; 36(12):108332.
    View in: PubMed
    Score: 0.021
  5. Doyle-Delgado K, Chamberlain JJ, Shubrook JH, Skolnik N, Trujillo J. Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline. Ann Intern Med. 2020 11 17; 173(10):813-821.
    View in: PubMed
    Score: 0.018
  6. Trujillo J. Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes. J Clin Pharm Ther. 2020 Sep; 45 Suppl 1:43-60.
    View in: PubMed
    Score: 0.018
  7. Lowe RN, Trujillo JM. Intranasal Glucagon: A New Way to Treat Hypoglycemic Emergencies. Ann Pharmacother. 2020 08; 54(8):780-787.
    View in: PubMed
    Score: 0.017
  8. Anderson SL, Beutel TR, Trujillo JM. Oral semaglutide in type 2 diabetes. J Diabetes Complications. 2020 04; 34(4):107520.
    View in: PubMed
    Score: 0.017
  9. Patel D, Triplitt C, Trujillo J. Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist. Adv Ther. 2019 05; 36(5):1031-1051.
    View in: PubMed
    Score: 0.016
  10. Trujillo JM, Roberts M, Dex T, Chao J, White J, LaSalle J. Low incidence of gastrointestinal adverse events over time with a fixed-ratio combination of insulin glargine and lixisenatide versus lixisenatide alone. Diabetes Obes Metab. 2018 11; 20(11):2690-2694.
    View in: PubMed
    Score: 0.016
  11. Tuchscherer RM, Thompson AM, Trujillo JM. Semaglutide: The Newest Once-Weekly GLP-1 RA for Type 2 Diabetes. Ann Pharmacother. 2018 12; 52(12):1224-1232.
    View in: PubMed
    Score: 0.015
  12. Johnson EL, Frias JP, Trujillo JM. Anticipatory guidance in type 2 diabetes to improve disease management; next steps after basal insulin. Postgrad Med. 2018 May; 130(4):365-374.
    View in: PubMed
    Score: 0.015
  13. Trujillo JM, Goldman J. Lixisenatide, a Once-Daily Prandial Glucagon-Like Peptide-1 Receptor Agonist for the Treatment of Adults with Type 2 Diabetes. Pharmacotherapy. 2017 Aug; 37(8):927-943.
    View in: PubMed
    Score: 0.015
  14. Goldman J, Trujillo JM. iGlarLixi: A Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide for the Treatment of Type 2 Diabetes. Ann Pharmacother. 2017 Nov; 51(11):990-999.
    View in: PubMed
    Score: 0.014
  15. Trujillo JM, Nuffer WA. Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Nonglycemic Outcomes in Patients with Type 2 Diabetes. Pharmacotherapy. 2017 Apr; 37(4):481-491.
    View in: PubMed
    Score: 0.014
  16. Trujillo JM, McNair CD, Linnebur SA, Valdez C, Trujillo TC. The Impact of a Standalone, Patient-centered Communication Course Series on Student Achievement, Preparedness, and Attitudes. Am J Pharm Educ. 2016 Dec 25; 80(10):174.
    View in: PubMed
    Score: 0.014
  17. Trujillo JM, Wettergreen SA, Nuffer WA, Ellis SL, McDermott MT. Cardiovascular Outcomes of New Medications for Type 2 Diabetes. Diabetes Technol Ther. 2016 12; 18(12):749-758.
    View in: PubMed
    Score: 0.014
  18. Nuffer WA, Trujillo JM. Liraglutide: A New Option for the Treatment of Obesity. Pharmacotherapy. 2015 Oct; 35(10):926-34.
    View in: PubMed
    Score: 0.013
  19. Trujillo JM, Figler TA. Teaching and learning health literacy in a doctor of pharmacy program. Am J Pharm Educ. 2015 Mar 25; 79(2):27.
    View in: PubMed
    Score: 0.012
  20. Thompson AM, Trujillo JM. Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes. Ann Pharmacother. 2015 Mar; 49(3):351-9.
    View in: PubMed
    Score: 0.012
  21. Trujillo JM, Nuffer W. GLP-1 receptor agonists for type 2 diabetes mellitus: recent developments and emerging agents. Pharmacotherapy. 2014 Nov; 34(11):1174-86.
    View in: PubMed
    Score: 0.012
  22. Trujillo JM, Nuffer W. Albiglutide: a new GLP-1 receptor agonist for the treatment of type 2 diabetes. Ann Pharmacother. 2014 Nov; 48(11):1494-501.
    View in: PubMed
    Score: 0.012
  23. Trujillo JM, Saseen JJ, Linnebur SA, Borgelt LM, Hemstreet BA, Fish DN. Impact of student- versus instructor-directed case discussions on student performance in a pharmacotherapy capstone course. Am J Pharm Educ. 2014 Apr 17; 78(3):56.
    View in: PubMed
    Score: 0.012
  24. DiVall M, Barr J, Gonyeau M, Matthews SJ, Van Amburgh J, Qualters D, Trujillo J. Follow-up assessment of a faculty peer observation and evaluation program. Am J Pharm Educ. 2012 May 10; 76(4):61.
    View in: PubMed
    Score: 0.010
  25. Anderson SL, Trujillo JM. Association of pancreatitis with glucagon-like peptide-1 agonist use. Ann Pharmacother. 2010 May; 44(5):904-9.
    View in: PubMed
    Score: 0.009
  26. Trujillo J. A drug interactions elective course. Am J Pharm Educ. 2009 Jul 10; 73(4):72.
    View in: PubMed
    Score: 0.008
  27. Trujillo JM, Hardy Y. A Nutrition Journal and Diabetes Shopping Experience to improve pharmacy students' empathy and cultural competence. Am J Pharm Educ. 2009 Apr 07; 73(2):37.
    View in: PubMed
    Score: 0.008
  28. Trujillo JM, DiVall MV, Barr J, Gonyeau M, Van Amburgh JA, Matthews SJ, Qualters D. Development of a peer teaching-assessment program and a peer observation and evaluation tool. Am J Pharm Educ. 2008 Dec 15; 72(6):147.
    View in: PubMed
    Score: 0.008
  29. Trujillo JM, Barsky EE, Greenwood BC, Wahlstrom SA, Shaykevich S, Pendergrass ML, Schnipper JL. Improving glycemic control in medical inpatients: a pilot study. J Hosp Med. 2008 Jan; 3(1):55-63.
    View in: PubMed
    Score: 0.007
  30. Trujillo JM, Gonyeau MJ, DiVall MV, Alexander SL. Spironolactone use in patients with heart failure. J Clin Pharm Ther. 2004 Apr; 29(2):165-70.
    View in: PubMed
    Score: 0.006
  31. Wright EE, Malone DC, Trujillo JM, Gill J, Huse S, Li X, Zhou FL, Preblick R, Reid T. Real-world persistence, adherence, health care resource utilization, and costs in people with type 2 diabetes switching from a first-generation basal insulin to a second-generation (insulin glargine 300 U/mL) vs an alternative first-generation basal insulin. J Manag Care Spec Pharm. 2022 Jun; 28(6):592-603.
    View in: PubMed
    Score: 0.005
  32. Rudolph M, Gortney JS, Brownfield A, Caldwell D, Castleberry A, Le UM, Medina MS, Sease JM, Trujillo J, Welch AC, Daugherty KK. Student perceptions of the utility of the Pharmacy Curriculum Outcomes Assessment. Curr Pharm Teach Learn. 2020 03; 12(3):255-264.
    View in: PubMed
    Score: 0.004
  33. Anderson SL, Trujillo JM, Anderson JE, Tanenberg RJ. Switching basal insulins in type 2 diabetes: practical recommendations for health care providers. Postgrad Med. 2018 Mar; 130(2):229-238.
    View in: PubMed
    Score: 0.004
  34. Saseen JJ, Linnebur SA, Borgelt LM, Trujillo J, Fish DN, Mueller S. A Pharmacotherapy Capstone Course to Target Student Learning and Programmatic Curricular Assessment. Am J Pharm Educ. 2017 Apr; 81(3):45.
    View in: PubMed
    Score: 0.004
  35. Haines ST, Pittenger AL, Stolte SK, Plaza CM, Gleason BL, Kantorovich A, McCollum M, Trujillo JM, Copeland DA, Lacroix MM, Masuda QN, Mbi P, Medina MS, Miller SM. Core Entrustable Professional Activities for New Pharmacy Graduates. Am J Pharm Educ. 2017 02 25; 81(1):S2.
    View in: PubMed
    Score: 0.004
  36. Nuffer W, Trujillo JM, Megyeri J. A Comparison of New Pharmacological Agents for the Treatment of Obesity. Ann Pharmacother. 2016 May; 50(5):376-88.
    View in: PubMed
    Score: 0.003
  37. Nuffer W, Trujillo JM, Ellis SL. Technosphere insulin (Afrezza): a new, inhaled prandial insulin. Ann Pharmacother. 2015 Jan; 49(1):99-106.
    View in: PubMed
    Score: 0.003
  38. Hume AL, Kirwin J, Bieber HL, Couchenour RL, Hall DL, Kennedy AK, LaPointe NM, Burkhardt CD, Schilli K, Seaton T, Trujillo J, Wiggins B. Improving care transitions: current practice and future opportunities for pharmacists. Pharmacotherapy. 2012 Nov; 32(11):e326-37.
    View in: PubMed
    Score: 0.003
  39. Anderson SL, Trujillo JM, McDermott M, Saseen JJ. Determining predictors of response to exenatide in type 2 diabetes. J Am Pharm Assoc (2003). 2012 Jul-Aug; 52(4):466-71.
    View in: PubMed
    Score: 0.003
  40. Gonyeau MJ, Trujillo J, DiVall M. Development of progressive oral presentations in a therapeutics course series. Am J Pharm Educ. 2006 Apr 15; 70(2):36.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)